These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 32583975)
1. Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus. Iqbal H; Straw S; Craven TP; Stirling K; Wheatcroft SB; Witte KK ESC Heart Fail; 2020 Oct; 7(5):2032-2041. PubMed ID: 32583975 [TBL] [Abstract][Full Text] [Related]
2. The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction. Jones DA; Wright P; Alizadeh MA; Fhadil S; Rathod KS; Guttmann O; Knight C; Timmis A; Baumbach A; Wragg A; Mathur A; Antoniou S Eur Heart J Cardiovasc Pharmacother; 2021 Sep; 7(5):398-404. PubMed ID: 32730627 [TBL] [Abstract][Full Text] [Related]
3. Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists. Daher J; Da Costa A; Hilaire C; Ferreira T; Pierrard R; Guichard JB; Romeyer C; Isaaz K Clin Drug Investig; 2020 Apr; 40(4):343-353. PubMed ID: 32144651 [TBL] [Abstract][Full Text] [Related]
5. Meta-Analysis of Direct Oral Anticoagulants Compared With Vitamin K Antagonist for Left Ventricle Thrombus. Mir T; Sattar Y; Attique HB; Hussain T; Alraies MC; Sheikh M; Qureshi WT Cardiovasc Revasc Med; 2022 Feb; 35():141-146. PubMed ID: 33722539 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of direct oral anticoagulants versus vitamin K antagonists for left ventricular thrombus: an updated systematic review and meta-analysis. Golukhova EZ; Berdibekov BS; Ruzina EV Kardiologiia; 2023 Feb; 63(2):19-26. PubMed ID: 36880139 [TBL] [Abstract][Full Text] [Related]
7. Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: Systematic Review of Current Literature. Kajy M; Shokr M; Ramappa P Am J Ther; 2020; 27(6):e584-e590. PubMed ID: 30730331 [TBL] [Abstract][Full Text] [Related]
8. Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: A Retrospective, Multicenter Study and Meta-Analysis of Existing Data. Cochran JM; Jia X; Kaczmarek J; Staggers KA; Rifai MA; Hamzeh IR; Birnbaum Y J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):173-178. PubMed ID: 33078629 [TBL] [Abstract][Full Text] [Related]
9. Improving the management of left ventricular thrombus in a tertiary cardiology centre: a quality improvement project. Rahunathan N; Hurdus B; Straw S; Iqbal H; Witte K; Wheatcroft S BMJ Open Qual; 2023 Jan; 12(1):. PubMed ID: 36631136 [TBL] [Abstract][Full Text] [Related]
10. Treatment of Left Ventricular Thrombus With Direct Oral Anticoagulants: A Retrospective Observational Study. Guddeti RR; Anwar M; Walters RW; Apala D; Pajjuru V; Kousa O; Gujjula NR; Alla VM Am J Med; 2020 Dec; 133(12):1488-1491. PubMed ID: 32598904 [TBL] [Abstract][Full Text] [Related]
11. Direct oral anticoagulants compared with warfarin in patients with left ventricular thrombus: a cohort study from China. Zhou Y; Zhang X; Lin Y; Peng W J Thorac Dis; 2024 Feb; 16(2):884-892. PubMed ID: 38505052 [TBL] [Abstract][Full Text] [Related]
12. Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction. Zhang Z; Si D; Zhang Q; Qu M; Yu M; Jiang Z; Li D; Yang P; Zhang W Heart Vessels; 2022 Mar; 37(3):374-384. PubMed ID: 34420077 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of Direct Acting Oral Anticoagulants in Treatment of Left Ventricular Thrombus. Fleddermann AM; Hayes CH; Magalski A; Main ML Am J Cardiol; 2019 Aug; 124(3):367-372. PubMed ID: 31126539 [TBL] [Abstract][Full Text] [Related]
14. Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus. Huang L; Tan Y; Pan Y ESC Heart Fail; 2022 Oct; 9(5):3519-3532. PubMed ID: 35894752 [TBL] [Abstract][Full Text] [Related]
15. Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial‡. Alcalai R; Butnaru A; Moravsky G; Yagel O; Rashad R; Ibrahimli M; Planer D; Amir O; Elbaz-Greener G; Leibowitz D Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):660-667. PubMed ID: 34279598 [TBL] [Abstract][Full Text] [Related]
16. Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis. Haller PM; Kazem N; Agewall S; Borghi C; Ceconi C; Dobrev D; Cerbai E; Grove EL; Kaski JC; Lewis BS; Niessner A; Rocca B; Rosano G; Savarese G; Schnabel RB; Semb AG; Sossalla S; Wassmann S; Sulzgruber P Eur Heart J Cardiovasc Pharmacother; 2024 Aug; 10(5):444-453. PubMed ID: 38845369 [TBL] [Abstract][Full Text] [Related]
17. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions. Cheng JW; Barillari G J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983 [TBL] [Abstract][Full Text] [Related]
18. Direct oral anticoagulants versus vitamin K antagonists for patients with left ventricular thrombus. Xu Z; Li X; Li X; Gao Y; Mi X Ann Palliat Med; 2021 Sep; 10(9):9427-9434. PubMed ID: 34628868 [TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus. Bass ME; Kiser TH; Page RL; McIlvennan CK; Allen LA; Wright G; Shakowski C J Thromb Thrombolysis; 2021 Aug; 52(2):517-522. PubMed ID: 33420896 [TBL] [Abstract][Full Text] [Related]
20. Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register. Palareti G; Antonucci E; Legnani C; Mastroiacovo D; Poli D; Prandoni P; Tosetto A; Pengo V; Testa S; Ageno W; BMJ Open; 2020 Nov; 10(11):e040449. PubMed ID: 33247017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]